Copyright
©The Author(s) 2017.
World J Diabetes. Dec 15, 2017; 8(12): 489-511
Published online Dec 15, 2017. doi: 10.4239/wjd.v8.i12.489
Published online Dec 15, 2017. doi: 10.4239/wjd.v8.i12.489
| NICE[14] and SIGN[15] |
| BMI > 30 kg/m2 |
| Previous history of macrosomic baby ≥ 4.5 kg |
| Previous history of GDM |
| Family history of diabetes (first-degree family member with diabetes) |
| Ethnic backgrounds |
| South Asian (India, Pakistan or Bangladesh) |
| Black Caribbean |
| Middle Eastern (Saudi Arabia, United Arab Emirates, Iraq, Jordan, Syria, Oman, Qatar, Kuwait, Lebanon or Egypt) |
| ADIPS[13] |
| Moderate risk factors for GDM |
| Ethnic backgrounds: Asian, Indian, Aboriginal, Torres Strait Islander, Pacific Islander, Maori, Middle Eastern, and non-White African |
| BMI 25-35 kg/m2 |
| High risk factors for GDM |
| Previous history of GDM |
| Previous history of high blood glucose |
| Age ≥ 40 yr |
| Family history of diabetes (1st degree relation with diabetes or a sister with GDM) |
| BMI > 35 kg/m2 |
| Previous history of macrosomic child ≥ 4.5 kg |
| PCOS |
| Medications: Corticosteroids, antipsychotics |
| ADA[12] |
| BMI > 25 kg/m2 |
| No physical activity |
| 1st degree relation with diabetes |
| Ethnic backgrounds (African-American, Latino, Native-American, Asian-American, Pacific Islander) |
| Previous macrosomic child > 9 lb |
| Previous history of GDM |
| Hypertension |
| HDL-C < 0.90 mmol/L and/or triglyceride > 2.82 mmol/L |
| PCOS |
| HbA1c ≥ 5.7% and previous IGT or IFG |
| Signs of insulin resistance such as acanthosis nigricans |
| History of CVD |
Table 2 Various diagnostic criteria for gestational diabetes mellitus and cut-off values
| Diagnostic criteria | Sample | WVB (mg/dL) | VP |
| O’Sullivan and Mahan (Women screened using 3-h 100 g OGTT and two cut-off values are required to diagnose GDM)[28,31] | Fasting | 90 | 90 mg/dL |
| 1 h | 165 | 165 mg/dL | |
| 2 h | 143 | 145 mg/dL | |
| 3 h | 127 | 125 mg/dL | |
| NDDG criteria (Women screened using 3-h 100 g OGTT and two cut-off values are required to diagnose GDM)[32] | Fasting | 90 | 105 mg/dL |
| 1 h | 170 | 190 mg/dL | |
| 2 h | 145 | 165 mg/dL | |
| 3 h | 125 | 145 mg/dL | |
| Carpenter and coustan criteria (Women screened using 3-h 100 g OGTT and two cut-off values are required to diagnose GDM)[33] | Fasting | 90 | 95 mg/dL |
| 1 h | 165 | 180 mg/dL | |
| 2 h | 143 | 155 mg/dL | |
| 3 h | 127 | 140 mg/dL | |
| WHO 1999 criteria (Women screened using 2-h 75 g OGTT and one cut-off value is required to diagnose GDM)[5] | Fasting | 126 mg/dL | |
| 2 h | 140 mg/dL | ||
| Recent IADPSG criteria (GDM) (Women screened using 2-h 75 g OGTT and one cut-off value is required to diagnose GDM)[8] | Fasting | 92 mg/dL | |
| 1 h | 180 mg/dL | ||
| 2 h | 153 mg/dL | ||
| Recent IADPSG criteria (Overt diabetes) (Women screened using 2-h 75 g OGTT and one cut-off value is required to diagnose GDM)[8] | Fasting | 126 mg/dL | |
| HbA1c | ≥ 6.5% | ||
| RPG | 200 mg/dL |
Table 3 Etiology and pathophysiology of gestational diabetes mellitus
| Insulin resistance |
| Pregnancy and obesity as states of low grade inflammation[48,49] |
| Adipocytokines |
| ↓ Adiponectin[51-53] |
| ↑ TNF-α[55-58] |
| ↑ IL-6[56,62-64] |
| ↑ Leptin[56,58,65,66] |
| ↑ AFABP[79] |
| ↑ RBP-4[69] |
| ?↑ Resistin[54,62,72] |
| ?↑ Visfatin[76,77] |
| ? Novel adipocytokines (Vaspin, Apelin and Omentin)[50] |
| Endothelial function and angiogenic growth factors[74,80,81] |
| ↓ EPC |
| ↓ SOD |
| ↑ eNOS |
| ↑ PAI-1 |
| ↑ sEng |
| ↑ sICAM-1 |
| ↑ sVCAM-1 |
| ↑ t-PA |
| ↑ PLGF |
| ↑ sFlt-1 |
| Proteomics biomarkers |
| Haptoglobin, protein SMG8 and apoptosis inducing factor-1[83] |
| Apolipoprotein CIII[84] |
| Peptides precursors of clusterin, isoform 1 of fibrinogen alpha chain and apolipoprotein CII[85] |
| Glycosylated fibronectin[86] |
| Transthyretin–retinol binding protein-retinol complex[87] |
| Pancreatic β-cell dysfunction |
| Autoimmunity[92] |
| Glucokinase gene defect[93] |
Table 4 Genetic variants studied in relation to gestational diabetes mellitus
| Gene | Location | Variant | Association |
| Genes related to insulin secretion | |||
| ABCC8 | 11p15.1 | tagGCC allele of exon 16 and the AGG allele of the R1273R | Significant[97] |
| KCNJ11 | 11p15.1 | E23K | Significant[98] |
| UCP-2 | 11q13 | UCP2-866G> A | Controversial[98] |
| MT-ND1 | mtDNA | T3398C mutation | Significant[100] |
| TCF7L2 | 10q25.3 | rs7903146 | Significant[101,102] |
| GCK | 7p15.3-p15.1 | rs1799884 (-30G/A) | Significant[105-107] |
| HNF4A | 20q13.12 | rs2144908, rs2425637 and rs1885088 | No association[105] |
| HNF1A | 12q24.2 | rs1169288, rs1800574 | No association[105,108] |
| Genes of insulin and insulin receptors | |||
| INS | 11p15.5 | INS-VNTR class-III allele | Controversial[110,111] |
| INSR | 19p13.3-p13.2 | INSR allele-1 Kpn I RFLP | Significant[112] |
| IGF2 | 11p15.5 | IGF2 Bam HI RFLP | Significant[112] |
| IGF2BP2 | 3q27.2 | rs4402960 | Significant[113-115] |
| IRS1 | 2q36 | rs1801278 (Gly972Arg) | Controversial[98,107] |
| Genes of insulin resistance | |||
| PPARG | 3p25 | rs1801282 | No association[107] |
| PPARGC1A | 4p15.1 | rs8192678 | No association[101,118] |
| ADRB3 | 8p11.23 | rs4994 (Trp64Arg) | Controversial[101,194,119-121] |
| SLC2A1 | 1p34.2 | SLC2A1 Xba I RFLP | No association[112] |
| ADIPOQ | 3q27 | rs1501299 | No association[101] |
| FOXC2 | 16q24.1 | -512C allele | No association[101] |
| HLA genes | |||
| HLA | 6p21 | DR3 and DR4 | Controversial[122,123,125] |
| HLA | 6p21 | DR3-DQ2/X, DR4-DQ8/X with positive autoantibodies | Associated[124] |
| HLA | 6p21 | DR7-DQ2/X, DR9-DQ9/X and DR14-DQ5/X | Associated[124] |
| HLA | 6p21 | DQB1 alleles | Associated[111] |
| Other genes | |||
| CAPN10 | 2q37.3 | SNP-19, SNP-43, SNP-44, SNP-63) | No association[98,101] |
| HFE | 6p21.3 | C282Y in Northern and Central European women | Associated[127] |
| HFE | 6p21.3 | H63D | No association[127] |
| MBL2 | 10q11.2 | rs1800450 (Gly54Asp) | Significant[128] |
| MBL2 | 10q11.2 | rs5030737 (Arg52Cys) | No association[128] |
| SERPINE1 | 7q22.1 | -675 4G/5G | Could be associated[130] |
Table 5 The ACOG recommendations of the caloric requirements, composition and distribution throughout the day in pregnant women with diabetes[167]
| Caloric requirements | ||
| Normal BMI | 30-35 kcal/kg per day | |
| < 90% of Normal BMI | 30-40 kcal/kg per day | |
| > 120% of Normal BMI | 24 kcal/kg per day | |
| Caloric composition | ||
| Complex, high-fiber CHO | 40%-50% | |
| Proteins | 20% | |
| Unsaturated fats | 30%-40% | |
| Caloric distribution | ||
| Breakfast | 10%-20% | |
| Lunch | 20%-30% | |
| Dinner | 30%-40% | |
| Snacks | Up to 30% |
- Citation: Mirghani Dirar A, Doupis J. Gestational diabetes from A to Z. World J Diabetes 2017; 8(12): 489-511
- URL: https://www.wjgnet.com/1948-9358/full/v8/i12/489.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i12.489
